SH3YL1 Inhibitors
The proposed category SH3YL1 inhibitors integrates a range of compounds that, while not directly targeting SH3YL1, may influence the cellular processes and pathways wherein SH3YL1 operates, especially those related to endocytosis. Wortmannin and LY294002, both PI3K inhibitors, underscore the potential significance of vesicular trafficking and endocytosis processes connected with SH3YL1. With Dynasore's specific targeting of dynamin, a key element in endocytosis, the connection between SH3YL1's role in endocytosis becomes evident. Clathrin-mediated endocytosis, influenced by inhibitors like Pitstop 2, Monodansylcadaverine, and Chlorpromazine, reinforces the intricate endocytic processes that SH3YL1 might partake in.
Further compounds, such as EIPA and MDC, focus on diverse cellular uptake mechanisms, from macropinocytosis to autophagy, hinting at the breadth of SH3YL1's potential involvement. Tyrosine kinase modulation, represented by Genistein, and Src family kinase influence, exemplified by SU6656, shed light on possible signaling cascades connected to SH3YL1. Lastly, Nystatin's action on lipid rafts emphasizes the fluid and multifaceted nature of cellular membrane dynamics that SH3YL1 might be a part of. Collectively, these compounds sketch a portrait of SH3YL1's potential cellular playground, intricately woven with endocytosis and related signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, affecting endocytosis and potentially influencing SH3YL1-related processes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore targets dynamin, affecting endocytosis processes that may involve SH3YL1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, affecting vesicular trafficking that may indirectly influence SH3YL1. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
As a clathrin inhibitor, it can influence clathrin-mediated endocytosis, potentially affecting SH3YL1. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
It targets clathrin-mediated endocytosis, which may have a bearing on SH3YL1's involvement in this process. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
This compound inhibits macropinocytosis, potentially affecting SH3YL1 if involved in this pathway. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Affecting clathrin-mediated endocytosis, its action might indirectly influence SH3YL1's function. | ||||||
SU6656 | 330161-87-0 | sc-203286 sc-203286A | 1 mg 5 mg | $57.00 $133.00 | 27 | |
By inhibiting Src family kinases, SU6656 can potentially modulate processes related to SH3YL1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein might affect pathways potentially linked to SH3YL1. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin disrupts lipid rafts, affecting endocytosis processes that might involve SH3YL1. | ||||||